drugset / Trial / NCT03555942

Luteal Phase-start Ovarian Stimulation With Corifollitropin Alfa

NCT03555942

Completed 44 enrolled Fundacion Dexeus
Non-randomizedSequentialOpen-labelTreatment

Summary

To evaluate the effect of random-start of ovarian stimulation initiated in the early follicular or luteal phase on the pharmacokinetics and follicular dynamics and embryo euploidy rates in oocyte donors treated with identical ovarian stimulation protocols with corifollitropin alfa and GnRH antagonist pituitary downregulation

Timeline

Start
2018-05-08
Primary completion
2021-11-30
Completion
2021-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Corifollitropin alfa Protein / enzyme biologic 150 ug Subcutaneous

Indications